From: Augmented reality for stroke rehabilitation during COVID-19
Outcome | Pre | Post | Difference | p Value |
---|---|---|---|---|
FMA-UE (max. 66)†| 38.85 ± 19.98 | 42.49 ± 19.44 | 3.64 ± 4.69 | 0.00002** |
FMA-LE (max. 34)†| 18.64 ± 8.26 | 22.56 ± 7.78 | 3.92 ± 4.84 | 0.00001** |
BBS (max. 56)†| 40.90 ± 11.87 | 43.13 ± 10.30 | 2.23 ± 5.70 | 0.019* |
FAC (max. 6)†| 4.54 ± 1.17 | 4.76 ± 1.21 | 0.22 ± 0.92 | 0.149 |
BI (max. 20)†| 16.31 ± 2.73 | 17.56 ± 2.53 | 1.25 ± 1.18 | 0.0007** |
SF-12v2 PCS (max. 100)†| 32.28 ± 12.25 | 37.10 ± 10.11 | 4.82 ± 9.11 | 0.002** |
SF-12v2 MCS (max. 100)†| 40.60 ± 17.25 | 45.54 ± 11.58 | 4.94 ± 13.05 | 0.023* |